Trial Profile
Denosumab and Alendronate, Examination of the effective of Glucocorticoid-induced Osteoporosis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2019
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 29 Jun 2018 New trial record